Effects of Almonds on Insulin Sensitivity in Prediabetes

NCT03126981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2019-07-24

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effects of consuming 1.5 oz almonds twice daily on insulin sensitivity and markers of cardiometabolic health in men and women with prediabetes.

Conditions

Interventions

OTHER

1.5 oz of whole, natural almonds

1.5 oz of whole, natural almonds

OTHER

Low-fat, high refined starches/sugars

Low-fat foods, high in refined starches and added sugars

Sponsors & Collaborators

  • Almond Board of California

    collaborator OTHER
  • Midwest Center for Metabolic and Cardiovascular Research

    lead OTHER

Principal Investigators

  • Kevin Maki, PhD · MB Clinical Research and Consulting LLC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2018-09-26
Completion
2018-09-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126981 on ClinicalTrials.gov